Go Pro

SeaStar Medical (ICU) Competitors

SeaStar Medical logo
$4.69 +0.94 (+25.07%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$4.84 +0.15 (+3.26%)
As of 10/2/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICU vs. OM, TELA, COCH, MDAI, and NNOX

Should you buy SeaStar Medical stock or one of its competitors? SeaStar Medical's main competitors and comparable companies include Outset Medical (OM), TELA Bio (TELA), Envoy Medical (COCH), Spectral AI (MDAI), and Nano-X Imaging (NNOX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does SeaStar Medical compare to Outset Medical?

Outset Medical (NASDAQ:OM) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk.

SeaStar Medical has lower revenue, but higher earnings than Outset Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$119.48M0.62-$81.65M-$4.09N/A
SeaStar Medical$1.23M16.82-$12.15M-$3.91N/A

Outset Medical has a beta of 1.99, indicating that its stock price is 99% more volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.09, indicating that its stock price is 209% less volatile than the broader market.

Outset Medical presently has a consensus target price of $10.00, suggesting a potential upside of 152.53%. SeaStar Medical has a consensus target price of $8.00, suggesting a potential upside of 70.58%. Given Outset Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Outset Medical is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

1.7% of SeaStar Medical shares are owned by institutional investors. 2.5% of Outset Medical shares are owned by company insiders. Comparatively, 0.7% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, SeaStar Medical had 2 more articles in the media than Outset Medical. MarketBeat recorded 5 mentions for SeaStar Medical and 3 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.34 beat SeaStar Medical's score of 0.28 indicating that Outset Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Outset Medical
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
SeaStar Medical
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Outset Medical has a net margin of -63.06% compared to SeaStar Medical's net margin of -795.51%. Outset Medical's return on equity of -61.67% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical-63.06% -61.67% -28.25%
SeaStar Medical -795.51%-162.75%-109.89%

Summary

Outset Medical beats SeaStar Medical on 11 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to TELA Bio?

TELA Bio (NASDAQ:TELA) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

TELA Bio has a beta of 1.36, suggesting that its stock price is 36% more volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.09, suggesting that its stock price is 209% less volatile than the broader market.

SeaStar Medical has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TELA Bio$80.28M0.64-$38.83M-$0.77N/A
SeaStar Medical$1.23M16.82-$12.15M-$3.91N/A

94.4% of TELA Bio shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 1.1% of TELA Bio shares are held by company insiders. Comparatively, 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, SeaStar Medical had 2 more articles in the media than TELA Bio. MarketBeat recorded 5 mentions for SeaStar Medical and 3 mentions for TELA Bio. TELA Bio's average media sentiment score of 0.57 beat SeaStar Medical's score of 0.28 indicating that TELA Bio is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TELA Bio
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SeaStar Medical
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

TELA Bio has a net margin of -51.53% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
TELA Bio-51.53% -1,320.81% -59.39%
SeaStar Medical -795.51%-162.75%-109.89%

TELA Bio currently has a consensus price target of $2.14, suggesting a potential upside of 87.97%. SeaStar Medical has a consensus price target of $8.00, suggesting a potential upside of 70.58%. Given TELA Bio's stronger consensus rating and higher possible upside, equities research analysts clearly believe TELA Bio is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TELA Bio
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

TELA Bio beats SeaStar Medical on 11 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to Envoy Medical?

SeaStar Medical (NASDAQ:ICU) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

SeaStar Medical has a beta of -1.09, suggesting that its share price is 209% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.97, suggesting that its share price is 97% more volatile than the broader market.

SeaStar Medical presently has a consensus target price of $8.00, suggesting a potential upside of 70.58%. Envoy Medical has a consensus target price of $2.00, suggesting a potential upside of 194.99%. Given Envoy Medical's higher possible upside, analysts plainly believe Envoy Medical is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Envoy Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Comparatively, 7.2% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, SeaStar Medical had 4 more articles in the media than Envoy Medical. MarketBeat recorded 5 mentions for SeaStar Medical and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 0.75 beat SeaStar Medical's score of 0.28 indicating that Envoy Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Envoy Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SeaStar Medical has a net margin of -795.51% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-795.51% -162.75% -109.89%
Envoy Medical -11,304.83%N/A -144.13%

SeaStar Medical has higher revenue and earnings than Envoy Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M16.82-$12.15M-$3.91N/A
Envoy Medical$207K252.84-$23.76M-$0.76N/A

Summary

Envoy Medical beats SeaStar Medical on 9 of the 14 factors compared between the two stocks.

How does SeaStar Medical compare to Spectral AI?

Spectral AI (NASDAQ:MDAI) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and dividends.

67.1% of Spectral AI shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 13.7% of Spectral AI shares are owned by company insiders. Comparatively, 0.7% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Spectral AI presently has a consensus price target of $4.00, suggesting a potential upside of 140.96%. SeaStar Medical has a consensus price target of $8.00, suggesting a potential upside of 70.58%. Given Spectral AI's stronger consensus rating and higher probable upside, equities research analysts plainly believe Spectral AI is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spectral AI
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Spectral AI has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.09, meaning that its stock price is 209% less volatile than the broader market.

In the previous week, SeaStar Medical had 3 more articles in the media than Spectral AI. MarketBeat recorded 5 mentions for SeaStar Medical and 2 mentions for Spectral AI. SeaStar Medical's average media sentiment score of 0.28 beat Spectral AI's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Spectral AI
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
SeaStar Medical
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Spectral AI has higher revenue and earnings than SeaStar Medical. Spectral AI is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spectral AI$15.39M3.47-$7.57M-$0.35N/A
SeaStar Medical$1.23M16.82-$12.15M-$3.91N/A

Spectral AI has a net margin of -69.27% compared to SeaStar Medical's net margin of -795.51%. Spectral AI's return on equity of 0.00% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Spectral AI-69.27% N/A -78.56%
SeaStar Medical -795.51%-162.75%-109.89%

Summary

Spectral AI beats SeaStar Medical on 12 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to Nano-X Imaging?

SeaStar Medical (NASDAQ:ICU) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, SeaStar Medical had 3 more articles in the media than Nano-X Imaging. MarketBeat recorded 5 mentions for SeaStar Medical and 2 mentions for Nano-X Imaging. SeaStar Medical's average media sentiment score of 0.28 beat Nano-X Imaging's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nano-X Imaging
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

SeaStar Medical has higher earnings, but lower revenue than Nano-X Imaging. SeaStar Medical is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M16.82-$12.15M-$3.91N/A
Nano-X Imaging$13.02M3.84-$75.02M-$2.14N/A

SeaStar Medical presently has a consensus target price of $8.00, suggesting a potential upside of 70.58%. Nano-X Imaging has a consensus target price of $4.33, suggesting a potential upside of 581.66%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.50

SeaStar Medical has a net margin of -795.51% compared to Nano-X Imaging's net margin of -926.05%. Nano-X Imaging's return on equity of -116.93% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-795.51% -162.75% -109.89%
Nano-X Imaging -926.05%-116.93%-100.67%

SeaStar Medical has a beta of -1.09, indicating that its share price is 209% less volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.28, indicating that its share price is 28% more volatile than the broader market.

Summary

Nano-X Imaging beats SeaStar Medical on 12 of the 17 factors compared between the two stocks.

Get SeaStar Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICU vs. The Competition

MetricSeaStar MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$20.67M$5.45B$7.14B$13.18B
Dividend YieldN/A1.80%2.53%16.78%
P/E Ratio-1.2024.90275.9726.04
Price / Sales12.0784.85672.32109.92
Price / CashN/A32.4377.6051.75
Price / Book1.715.7310.936.31
Net Income-$12.15M$152.68M$3.51B$362.16M
7 Day Performance37.13%-1.71%-2.00%-1.66%
1 Month Performance61.17%-4.81%-6.15%-4.50%
1 Year Performance-27.69%1.08%7.44%2.06%

SeaStar Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICU
SeaStar Medical
2.8245 of 5 stars
$4.69
+25.1%
$8.00
+70.6%
-31.5%$20.67M$1.71MN/A2
OM
Outset Medical
2.9777 of 5 stars
$3.03
+2.4%
$10.00
+230.0%
-71.9%$55.64M$119.48MN/A310
TELA
TELA Bio
3.9754 of 5 stars
$1.24
+0.8%
$2.14
+72.8%
-24.5%$55.53M$80.28MN/A218
COCH
Envoy Medical
2.508 of 5 stars
$0.71
+2.4%
$2.00
+182.1%
-10.3%$53.43M$240KN/A47
MDAI
Spectral AI
1.8238 of 5 stars
$1.58
-1.9%
$4.00
+153.2%
-29.4%$51.82M$19.65MN/A65

Related Companies and Tools


This page (NASDAQ:ICU) was last updated on 10/3/2026 by MarketBeat.com Staff.
From Our Partners